Viewing Study NCT05945368

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:48 PM
Ignite Modification Date: 2026-02-03 @ 12:29 PM
Study NCT ID: NCT05945368
Status: UNKNOWN
Last Update Posted: 2023-07-14
First Post: 2023-05-28
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BC
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HER2-positive Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Early or locally advanced breast cancer View
None HER 2-positive View